WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007096536) ANTI-IDIOTYPIC ANTIBODY WHICH NEUTRALIZES THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST THE C1 DOMAIN OF FACTOR VIII
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/096536    International Application No.:    PCT/FR2007/000342
Publication Date: 30.08.2007 International Filing Date: 26.02.2007
IPC:
C07K 16/42 (2006.01), C12N 5/12 (2006.01), C12N 15/13 (2006.01), A61K 39/395 (2006.01), G01N 33/577 (2006.01), A61P 7/04 (2006.01)
Applicants: LFB BIOTECHNOLOGIES [FR/FR]; 3, avenue des Tropiques, ZA de Courtaboeuf, F-91940 Les Ulis (FR) (For All Designated States Except US).
GILLES, Jean-Guy [BE/BE]; (BE) (For US Only).
JACQUEMIN, Marc, G. [BE/BE]; (BE) (For US Only).
SAINT-REMY, Jean-Marie [BE/BE]; (BE) (For US Only).
BEHRENS, Christian [DE/FR]; (FR) (For US Only)
Inventors: GILLES, Jean-Guy; (BE).
JACQUEMIN, Marc, G.; (BE).
SAINT-REMY, Jean-Marie; (BE).
BEHRENS, Christian; (FR)
Agent: HIRSCH, Marc-Roger; Cabinet Hirsch-Pochart & Associés, 58, avenue Marceau, F-75008 Paris (FR)
Priority Data:
0601633 24.02.2006 FR
Title (EN) ANTI-IDIOTYPIC ANTIBODY WHICH NEUTRALIZES THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST THE C1 DOMAIN OF FACTOR VIII
(FR) ANTICORPS ANTI-IDIOTYPIQUES NEUTRALISANT L'ACTIVITE INHIBITRICE D'UN ANTICORPS INHIBITEUR DIRIGE CONTRE LE DOMAINE C1 DU FACTEUR VIII
Abstract: front page image
(EN)The present invention relates to an anti-idiotypic monoclonal antibody directed against a factor VIII-inhibiting antibody which binds to the C1 domain of factor VIII, and also to a cell line which produces this anti-idiotypic monoclonal antibody, to the use of this anti-idiotypic monoclonal antibody as a medicament, and more particularly to its use for the manufacture of a medicament for use in the treatment of haemophilia A.
(FR)La présente invention se rapporte à un anticorps monoclonal anti-idiotypique dirigé contre un anticorps inhibiteur du facteur VIII se liant au domaine C1 du facteur VIII, ainsi qu'à une lignée cellulaire produisant cet anticorps monoclonal anti-idiotypique, à l'utilisation de cet anticorps monoclonal anti-idiotypique comme médicament, et plus particulièrement à son utilisation pour la fabrication d'un médicament destiné au traitement de l'hémophilie A.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)